Note: Ingredients listed on restricted chemical lists
EC/CAS
276-737-9/72623-86-0
Name of the chemical
Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based
Concentration
30 - 60
General Information
Version
7.0
Revision date
2023-02-15
Product name
MASTEROIL ZHM FLUID
1.2.1 Relevant identified uses
Industrial use,Professional use,Consumer use Industrial/Professional use spec Non-dispersive use Used in closed systems
Emergency telephone
+353 1 809 2566, +353 1 809 2166, +972 4 854 1900, +356 2545 6508, +46 10 456 6700
Icons in SDS
Company Information
company name
masteroil GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@masteroil.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H332
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Danger
Contains
1-Decene, dimer, hydrogenated; Hydrocarbons, C16-C20, n-alkanes, isoalkanes, cyclics, <2% aromatics
Hazard statements
H304 - May be fatal if swallowed and enters airways. H332 - Harmful if inhaled.
Precautionary statements
P271 - Use only outdoors or in a well-ventilated area. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P331 - Do NOT induce vomiting. P405 - Store locked up. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
